C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
The importance of RDW in obstructive sleep apnea syndrome. Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Relationship between adiponectin gene polymorphism and obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006
Creatine phosphokinase elevation is highly predictive of obstructive sleep apnoea syndrome (OSAS) in patients with suspected sleep disordered breathing Source: Eur Respir J 2005; 26: Suppl. 49, 114s Year: 2005
Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004